Nonbenzodiazepine anticonvulsants

25,295views

test

00:00 / 00:00

Nonbenzodiazepine anticonvulsants

Surgery

Surgery

Preoperative evaluation: Clinical
Postoperative evaluation: Clinical
General anesthetics
Local anesthetics
Neuromuscular blockers
Protein synthesis inhibitors: Aminoglycosides
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Laxatives and cathartics
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Insulins
Abdominal pain: Clinical
Esophageal surgical conditions: Clinical
Gastrointestinal bleeding: Clinical
Peptic ulcers and stomach cancer: Clinical
Appendicitis: Clinical
Appendicitis: Pathology review
Diverticular disease: Clinical
Hernias: Clinical
Bowel obstruction: Clinical
Colorectal cancer: Clinical
Abdominal trauma: Clinical
Anal conditions: Clinical
Gallbladder disorders: Clinical
Gallbladder disorders: Pathology review
Pancreatitis: Clinical
Pancreatitis: Pathology review
Adrenal masses and tumors: Clinical
Breast cancer: Clinical
Breast cancer: Pathology review
Benign breast conditions: Pathology review
Skin and soft tissue infections: Clinical
Anatomy clinical correlates: Anterior and posterior abdominal wall
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Anatomy clinical correlates: Peritoneum and diaphragm
Anatomy clinical correlates: Other abdominal organs
Coronary artery disease: Clinical
Valvular heart disease: Clinical
Pericardial disease: Clinical
Aortic aneurysms and dissections: Clinical
Chest trauma: Clinical
Reading a chest X-ray
Pleural effusion: Clinical
Pneumothorax: Clinical
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Lung cancer: Clinical
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Pleura and lungs
Anatomy clinical correlates: Mediastinum
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
cGMP mediated smooth muscle vasodilators
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Benign hyperpigmented skin lesions: Clinical
Skin cancer: Clinical
Blistering skin disorders: Clinical
Bites and stings: Clinical
Burns: Clinical
Dizziness and vertigo: Clinical
Thyroid nodules and thyroid cancer: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Neck trauma: Clinical
Nasal, oral and pharyngeal diseases: Pathology review
Antihistamines for allergies
Stroke: Clinical
Seizures: Clinical
Headaches: Clinical
Traumatic brain injury: Clinical
Brain tumors: Clinical
Lower back pain: Clinical
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Spinal cord pathways
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Migraine medications
Migraine
Osmotic diuretics
Thrombolytics
Shock: Clinical
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Anatomy and physiology of the eye
Pediatric ophthalmological conditions: Clinical
Joint pain: Clinical
Back pain: Pathology review
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Axilla
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Anatomy clinical correlates: Bones, joints and muscles of the back
Concussion and traumatic brain injury
Traumatic brain injury: Pathology review
Abdominal hernias
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Kidney stones: Clinical
Renal cysts and cancer: Clinical
Urinary incontinence: Pathology review
Testicular and scrotal conditions: Pathology review
Anatomy clinical correlates: Male pelvis and perineum
Anatomy clinical correlates: Female pelvis and perineum
Androgens and antiandrogens
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Peripheral vascular disease: Clinical
Leg ulcers: Clinical
Aortic dissections and aneurysms: Pathology review

Assessments

Flashcards

0 / 45 complete

USMLE® Step 1 questions

0 / 7 complete

USMLE® Step 2 questions

0 / 10 complete

Flashcards

Nonbenzodiazepine anticonvulsants

0 of 45 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 7 complete

USMLE® Step 2 style questions USMLE

0 of 10 complete

A 30-year-old woman comes to the physician with a fever and sore throat. The patient’s symptoms started two days ago. She was diagnosed with a partial seizure last month and was started on anti-epileptic medication. Temperature is 38°C (100.4 °F), blood pressure is 120/80 mmHg, and pulse is 89 beats per minute. Laboratory results are shown below. Which of the following medications is this patient most likely taking?

 Erythrocyte count   5 million (cells/mcL) 
 Hemoglobin   13 (g/dL) 
 Mean corpuscular volume   80 (fL) 
 Leukocyte count   1500 (cells/mm3) 
 Absolute Neutrophil count   80 (cells/mm3) 
 Platelets count   200,000/mm3

External References

First Aid

2024

2023

2022

2021

Carbamazepine

agranulocytosis p. 249

aplastic anemia p. 249

bipolar disorder p. 578, 724

cytochrome P-444 and p. 251

epilepsy p. 560

SIADH and p. 248

teratogenicity p. 632

tonic-clonic seizures p. 724

trigeminal neuralgia p. 724

Transcript

Watch video only

Anticonvulsants are a type of medication used to treat the various types of seizure disorders.

These include benzodiazepines and barbiturates which increase the activity of inhibitory neurons, but there are also many other classes of anticonvulsants with different mechanisms that we’ll talk about in this video.

Okay, so the cells that make up our brain are called neurons.

Neurons communicate with each other through neurotransmitters.

When one neuron is stimulated, it releases excitatory neurotransmitters that bind to receptors on the next neuron. This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.

The main excitatory neurotransmitter in our brain is glutamate which can bind to several types of receptors that are basically ligand-gated ion channels, which open up and allow Na+ and Ca2+ to flow in, and K+ to flow out.

In the end, when it’s all added up, there’s an influx of positive charge that makes the cell less negative,and the neuron becomes depolarized. This causes nearby voltage-gated Na+ channels to open on the surface of the membrane, causing more Na+ to enter. This in turn triggers other nearby voltage-gated Na+ channels to open.

So this series of depolarization travels down the neuron like a wave and it’s called an action potential.

When it reaches the end of the neuron, called the synaptic terminal, it triggers the opening of voltage-gated Ca2+ channels, causing an influx of calcium ions which stimulates the release of neurotransmitters that are stored in synaptic vesicles.

Okay, we also have inhibitory neurons that shut down this chain of events.

These neurons release the main inhibitory neurotransmitter called gamma-aminobutyric acid or GABA, which binds to GABA receptors on other neurons.

These GABA receptors are also ligand-gated ion channels, but they open up to let the negatively charged Cl-, into the cell.

The influx of negative ions causes hyperpolarization where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential.

Alright, now there are cases where neurons in the brain start sending out more excitatory signals than normal. This can occur due to either too much excitation or too little inhibition in the brain.

Excessive excitatory signals can cause a variety of disorders like seizures and epilepsy.

Seizures are categorized based on the region of the brain that’s affected.

When it’s limited to one hemisphere or a single lobe, we call it a focal or partial seizure, and these can cause the person to experience strange sensations, like hearing or tasting something that isn’t there, but can also involve jerking movements in specific muscle groups if the neurons controlling these muscles are affected.

A generalized seizure is where both hemispheres of the brain are affected.

Tonic-clonic seizures are the most common generalized seizures, where patients experience a tonic phase, where the muscles suddenly tense up, followed by the clonic phase, where the muscles rapidly contract and relax.

Another type of generalized seizure is absence seizures, where the person has impaired awareness or responsiveness, generally with the only outward sign being that the person looks like they “spaced out.”

If the seizures themselves last longer than 5 minutes without stopping, or if there are multiple seizures without returning to normal in between, then it’s called status epilepticus.

Okay, so we can manage seizure disorders by increasing the effect of inhibitory neurons or decreasing the activity of excitatory neurons.

Let’s start with a group of medications that block voltage-gated sodium channels, which inhibit the action potentials in excitatory neurons. These include carbamazepine, valproic acid, phenytoin, lamotrigine, and topiramate. Some of these medications have other mechanisms as well.

Lamotrigine and topiramate inhibit the release of glutamate; and topiramate also inhibits voltage-gated calcium channels.

Valproic acid inhibits GABA transaminase, which is an enzyme that breaks down GABA in the inhibitory neurons.

So valproic acid inhibits the metabolism of GABA, increases GABA concentration in the brain and enhances the effect of inhibitory neurons.

Okay moving on to indications. Carbamazepine, valproic acid, lamotrigine, topiramate and phenytoin are commonly used for the treatment of partial and generalized tonic-clonic seizures.

In addition, lamotrigine and valproic acid are used for absence seizures.

For the prophylaxis of status epilepticus, phenytoin and its prodrug, fosphenytoin, are considered the medications of choice.

Apart from seizures and epilepsy, carbamazepine, lamotrigine, and valproic acid are also used as mood stabilizers for bipolar disorder.

Note also that carbamazepine is the first line treatment for trigeminal neuralgia which is a disorder characterized by shooting pain in the distribution of the trigeminal nerve.

Finally, valproic acid and topiramate are also used as prophylactic therapy for migraines and cluster headaches.

Alright let’s move on to side effects. Carbamazepine can cause diplopia or double vision, ataxia, agranulocytosis, liver toxicity, and SIADH or syndrome of inappropriate antidiuretic hormone secretion.

A rare but potentially fatal side effect of carbamazepine is Stevens Johnson syndrome, which is characterized by rapid desquamation of the skin.

Note also that carbamazepine is not safe to use during pregnancy because it increases the risk of congenital defects like cleft lip or palate, and neural tube defects such as spina bifida.

Also, carbamazepine induces a class of enzymes called cytochrome P450. These enzymes are involved in the metabolism of various medications like benzodiazepines, phenytoin, quinidine, warfarin, and others. Increased cytochrome P450 activity can result in these medications being broken down too rapidly, so larger doses are needed to achieve a therapeutic effect.

Okay, now common side effects of lamotrigine include blurred vision and gastrointestinal symptoms, like nausea and vomiting.

If levels increase, lamotrigine can cause Stevens Johnson syndrome and thus serum levels should be monitored closely.

Now side effects of phenytoin include visual disturbances like nystagmus, or involuntary eye movement; diplopia; ataxia; hirsutism or excessive hair growth; and gingival hyperplasia or enlarged gums.

Phenytoin also inhibits the absorption of folate in the small intestine and so it can lead to megaloblastic anemia.

In addition, phenytoin induces cytochrome P450 just like carbamazepine.

Rare adverse effects include Stevens Johnson syndrome and symptoms that mimic systemic lupus erythematosus, or SLE-like syndrome.

Keep in mind that phenytoin is not safe to use during pregnancy.

Teratogenic effects include intrauterine growth restriction or IUGR, intellectual disability, cleft lip or palate, and congenital heart defects.

Common side effects of valproic acid are gastrointestinal symptoms like nausea and vomiting, tremors, sedation, alopecia or loss of hair, weight gain, and blood disorders like a low platelet and white blood cell count.

A rare but life-threatening adverse effect is liver toxicity.

Summary

Nonbenzodiazepine anticonvulsants are a class of drugs used to treat seizures, headaches, and neuropathic pain. These drugs are also used as mood stabilizers for bipolar disorders. Nonbenzodiazepine anticonvulsants decrease excitatory signals in the brain, primarily by blocking sodium and calcium channels, or by enhancing the actions of GABA. This lead to a decrease in the abnormal electrical activity in the brain responsible for the associated symptoms.

Common examples of nonbenzodiazepine anticonvulsants include carbamazepine, lamotrigine, and valproic acid. Side effects include double vision, ataxia, and liver toxicity for carbamazepine; Stevens Johnson syndrome for lamotrigine; and teratogenic effects like neural tube defects for valproic acid.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents" Cochrane Database Syst Rev (2017)
  5. "Adverse effects of antiepileptic drugs: a brief overview of important issues" Expert Rev Neurother (2010)
  6. "Antiepileptic action induced by a combination of vigabatrin and tiagabine" Neuroscience (2005)